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High prevalence of carpal tunnel syndrome in
individuals with rare nerve growth factor-beta
mutation
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In Sweden, a large family with a point mutation in the nerve growth factor-beta gene has previously been identified. The carriers of this mu-
tation have reduced small-fibre density and selective deficits in deep pain and temperature modalities. The clinical findings in this population
are described as hereditary sensory and autonomic neuropathy type V. The purpose of the current study was to investigate the prevalence
of carpal tunnel syndrome in hereditary sensory and autonomic neuropathy type V based on clinical examinations and electrophysiological
measurements. Furthermore, the cross-sectional area of the median nerve at the carpal tunnel inlet was measured with ultrasonography. Out
of 52 known individuals heterozygous for the nerve growth factor-beta mutation in Sweden, 23 participated in the current study (12 males,
11 females; mean age 55years; range 25–86years). All participants answered a health questionnaire and underwent clinical examination fol-
lowed by median nerve conduction study in a case–control design, and measurement of the nerve cross-sectional area with ultrasonography.
The diagnosis of carpal tunnel syndrome was made based on consensus criteria using patient history and nerve conduction study. The
prevalence of carpal tunnel syndrome in the hereditary sensory and autonomic neuropathy group was 35% or 52% depending on whether
those individuals who had classic symptoms of carpal tunnel syndrome but negative nerve conduction studies were included or not. Those
who had a high likelihood of carpal tunnel syndrome based on classic/probable patient history with positive nerve conduction study had a
significantly larger median nerve cross-sectional area than those who had an unlikely patient history with negative nerve conduction study.
The prevalence of carpal tunnel syndrome was 10–25 times higher in individuals heterozygous for the nerve growth factor-beta mutation
than the general Swedish population. Further studies are needed to better understand the underlying pathophysiological mechanisms.
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Introduction
Hereditary sensory and autonomic neuropathies are rare
genetic conditions that can be classified into five subtypes
(HSANs I–V) based on their mode of inheritance, natural
history, pathology, biochemical and neurophysiological fea-
tures and degree of autonomic involvement (Dyck et al.,
1983). We have previously identified a large family residing
in northern Sweden with a condition best fitting the
HSANV subtype (Minde et al., 2004). They have a point
mutation in the gene encoding nerve growth factor-beta on
chromosome 1p11.2–p13.2, and the pattern of inheritance
is autosomal recessive (Einarsdottir et al., 2004).
Individuals with HSANV have a normal cognitive func-
tion (Minde et al., 2004). Heterozygous carriers—the
focus of the current study—have milder symptoms than
their homozygous counterparts, a moderate reduction in
Ad and C fibres in sural nerve biopsies, and the clinical
picture ranges from asymptomatic cases to Charcot
arthropathy starting in adult life (20–30 years old in
some cases) but is most common above 70 years (Minde
et al., 2009). In a previous study on the phenotype of
heterozygous carriers, a serendipitous finding was that a
proportion of them were vulnerable to carpal tunnel syn-
drome (CTS) (Minde et al., 2009). However, that study
was not designed to assess the prevalence of CTS, and
the clinical examination was unstructured. Evidence from
clinical studies suggests a disturbance in small-fibre func-
tion in patients with CTS, including reduced laser-evoked
brain potentials (Arendt-Nielsen et al., 1991), increased
thermal detection thresholds (Schmid et al., 2014),
reduced intraepidermal nerve fibre density (Schmid et al.,
2014) and decreased sympathetic skin response (Kiylioglu
et al., 2005; cf. Bayrak et al., 2007) and vasomotor func-
tion (Wilder-Smith et al., 2003). The prevalence of CTS
in the general population in Sweden is estimated to be
2.1–3.6% (Atroshi et al., 1999).
CTS is a median nerve compression neuropathy at the
wrist presenting as a varied combination of numbness,
tingling and pain in the median nerve territory of the
hand that sometimes radiates up the forearm. In mild-to-
moderate cases, the symptoms are intermittent and often
worse at night and after physical activity. Severe cases
have persistent sensory loss, motor disturbances with
weak thumb abduction and thenar muscle atrophy
(Dawson, 1993). Diagnosis is classically made by a com-
bination of patient history, clinical examination and nerve
conduction study (NCS).
Ultrasonography has emerged as a possible adjunct to
NCS in the diagnosis of CTS since it is less time consum-
ing and not unpleasant for the patient (Ghasemi-Rad
et al., 2014). In CTS, the nerve becomes swollen at the
carpal tunnel inlet and a large cross-sectional area (CSA)
at this level is a diagnostic feature. Varied concordance
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with NCS has been shown good in some studies and
poor in others. Many have tried to establish the best cut-
off value for the median nerve CSA at the carpal tunnel
inlet in the diagnosis of CTS, but the proposed values
vary widely from 6.5 to 15 mm2 (Pinilla et al., 2008;
Sarraf et al., 2014).
For epidemiological research, a consensus regarding the
classification of CTS was presented by Rempel et al.
(1998) where patient history was divided into three cate-
gories: classic/probable, possible and unlikely. This was
combined with NCS being either negative or positive (see
Tables 1 and 2).
The aim of the current study was to determine the
prevalence of CTS in the heterozygous group, using the
aforementioned consensus criteria (Rempel et al., 1998)
and to measure the CSA of the median nerve at the car-
pal tunnel inlet with ultrasonography.
Materials and methods
Study group
There are 52 known individuals who are heterozygous
for the 1p11.2–p13.2 mutation in Sweden. Of these, four
were excluded from the study due to age (under 15 or
above 85 years), and another four were excluded because
they had previously participated in at least one study and
had expressed no interest in further studies. Out of 44
heterozygotes who were invited to participate in the
study, 23 volunteered (44% of known heterozygotes),
while 29 chose not to participate because of work, study,
length of travel or personal reasons. There were 12 males
(52%) and 11 females (48%) in the HSANV group. The
mean age was 55 years (range 25–86) and the median
age was 59 years. Five relatives without the nerve growth
factor-beta mutation also volunteered to participate [1
male, 4 females; mean age 54 (range 25–72) years; me-
dian age, 59 years]; data for these are shown in
Supplementary Table 1. To compare NCS data, a group
of 30 healthy participants (20–79 years, 18 females, 12
males) served as controls. All volunteers gave informed
written consent to participate in the study, which was
approved by the ethics committee of the Umeå University
and complied with the revised Declaration of Helsinki.
Patient history and clinical
examination
Each patient received by mail a screening questionnaire
regarding their general health, medications, symptoms of
neuropathy and whether their occupation included work
with vibrating tools. Manual work with repetitive wrist
motion, forceful hand movements and the use of vibrat-
ing tools increase the risk of developing CTS (Newington
et al., 2015; Guan et al., 2018).
Clinical examination was performed by a single phys-
ician (M.R.) working as an orthopaedic surgeon. Patient
history was collected and classified as classic/probable,
possible or unlikely for CTS as described in Tables 1 and
2. If the patient previously had surgery for suspected
CTS and was relieved of symptoms, this was classified as
classic/probable CTS. The surgically treated wrists are
described separately in the Results.
Clinically all wrists were assessed for Tinel’s sign (posi-
tive or negative) and Phalen’s test for 60 s (positive or
negative and after how many seconds did the symptoms
occur in each hand). Phalen’s test involves a prolonged
maximal flexion of the patient’s wrist to see whether this
triggers or aggravates paresthaesia in the median nerve
territory, and Tinel’s sign involves tapping over the car-
pal tunnel to see whether this elicits paresthaesia/tingling
(Ghasemi-Rad et al., 2014).
It was also noted whether the patient had symptoms
and clinical signs of ulnar entrapment based on patient
history with numbness/tingling in an ulnar nerve distribu-
tion and/or weakness of ulnar nerve-innervated muscula-
ture. During the clinical examination, motor and sensory
functions of the ulnar nerve were tested and Tinel’s test
was performed over the nerve in the cubital tunnel as
well as in Guyon’s canal. Patients were also asked if they
Table 1 Classification of patient history for CTS
Symptoms Description
Classic/probable Numbness, tingling, burning or pain in at least two digits of digiti I, II and IIIWrist pain, palm pain or proximal radiation is allowed
Possible Numbness, tingling, burning or pain in at least one digit of digiti I, II and III
Unlikely No symptoms in digitus I, II or III
Reproduced from Rempel et al. (1998).
Table 2 Consensus criteria for CTS based on patient
history and NCS








From Rempel et al. (1998).
aNo consensus whether it should be classified as CTS or not.
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had a history of neck pain and pain radiating down the
arm to screen for cervical radiculopathy.
Nerve conduction studies
NCS was performed by an experienced biomedical techni-
cian (O.T.), who was blind to patient history and results
from the clinical examination, following a standardized
procedure used in clinical practice at the Department of
Clinical Neurophysiology at the Linköping University
Hospital. The results were analysed by a clinical neuro-
physiologist (M.S.). Both motor and sensory studies were
done on the median nerve with a comparative sensory
study of the ulnar nerve. For motor measurements, stimu-
lation was performed proximal to the wrist and registra-
tion was done over abductor pollicis brevis and abductor
digiti minimi muscles for the median and ulnar nerves,
respectively. Sensory responses were recorded orthodrom-
ic by digital stimulation with ring electrodes and registra-
tion proximal to the wrist over the corresponding nerves
(third and fourth fingers for the median nerve and the
fourth finger for the ulnar nerve; for the fourth finger,
the same distance between stimulation and registration
was used for both median and ulnar recordings). The
electrophysiological diagnosis of CTS was based on a sig-
nificant difference in sensory conduction velocity between
the median and ulnar nerves, i.e. a difference in distal la-
tency of >0.6 ms when stimulating at the fourth digit
and recording compound sensory potentials from the me-
dian and ulnar nerves. In moderate-to-severe cases, there
was also an increased distal motor latency for the median
nerve (>4.2 ms) (Table 3). This is a modified version of
the criteria proposed by Bland (2000) in which fewer
grades are used, the threshold values are adapted to local
experience and, instead of using the biphasic sensory re-
sponse of the fourth finger, the latency difference between
the median and ulnar nerves is used to define a very
mild CTS.
Ultrasonography
All ultrasound examinations were performed by a single
radiologist (T.M.) with 12 years’ experience of musculo-
skeletal ultrasound examinations. The radiologist was
blinded to the results from the clinical examination and
the nerve conduction studies. The examinations were per-
formed using a General Electric Logic E9 ultrasound
machine with an ML-6/15 linear array transducer (GE
Healthcare, Chicago, IL, USA). All patients were seated
during examination with the wrist supported on a gel
pad, fingers extended, hand fully supinated, elbows flexed
to 90 and shoulders in a neutral position. Transverse
images of the median nerve were obtained at the carpal
tunnel inlet at the level of the scaphoid bone. The CSA
was measured perpendicular to the nerve using the trace
volume function inside the hyperechoic rim of the nerve.
Measurements were taken for both right and left wrists.
Statistical analysis
A Chi-square test was used to assess differences between
the HSANV and the control group regarding the occur-
rence of electrophysiological CTS. Kruskal–Wallis and
post hoc Dunn’s multiple comparisons tests were used to
compare ultrasonography results between patient groups
based on the likelihood of CTS. We considered P < 0.05
as statistically significant. Data were analysed in SPSS
(version 25; IBM Corporation, Armonk, NY, USA) and
GraphPad Prism (version 6.07; GraphPad Software Inc.,
La Jolla, CA, USA).
Data availability
Raw data were generated at the Department of
Orthopaedics, Gällivare Hospital. Derived data support-
ing the findings of this study are available from the cor-
responding author on request.
Results
Clinical examination
Out of 23 patients who were tested bilaterally, 4 (17%)
of these previously had surgery for CTS (3 bilaterally
and 1 only on the left side) (Table 4). All were relieved
of the symptoms they had before surgery and were there-
fore included in the classic/probable group. The patient
who previously had surgery only on the left wrist had
now developed classic/probable symptoms on the right
wrist. With the inclusion of the surgically treated
patients, there were 11 (48%) with a classic/probable his-
tory, 2 (9%) with a possible history and 10 (44%) with
an unlikely history for CTS. All patients in the classic/
probable and possible groups have (or previously had) bi-
lateral symptoms.
In the 11 patients with classic/probable CTS, Phalen’s
test was positive with a mean time of 32 s (range 10–
60 s). Out of seven surgically treated wrists, six still had
a positive Phalen’s test with a mean time of 37 s. In the
two patients with a possible history of CTS, one had a
negative Phalen’s test on both sides while the other had a
negative test on the right side and a positive test after
40 s on the left side. For the 10 patients with an unlikely
history of CTS, Phalen’s test was negative in eight and
Table 3 Quantitative classification of median nerve
dysfunction during NCS
1. Very mild Increased sensory latency median nerve digit
IV >0.6 ms
2. Mild 1þ decreased sensory conduction velocity/amplitude
digit III
3. Moderate 2þ increased distal motor latency in median
nerve >4.2 ms
4. Severe Same as 3 but with no sensory response
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positive in two (one with a bilateral positive result after
40 s, and the other with a positive result after 30 s in the
left hand only).
Out of the 46 examined wrists, Tinel’s sign was posi-
tive in 4 wrists (right side in 2 patients with previous bi-
lateral surgery, and bilaterally in 1 patient with classic/
probable history). Marked thenar atrophy was found in
one patient with classic/probable history who had a posi-
tive Phalen’s test after 10 s bilaterally; the same patient
also had symptoms and clinical features of ulnar entrap-
ment in the elbow on the left side. Suspected ulnar en-
trapment in the elbow was also found in three more
patients, two with mild ulnar symptoms bilaterally (one
in the classic/probable group and the other in the unlike-
ly group) and one with an affected left side (classic/prob-
able group). Clinically there were no cases with suspected
cervical radiculopathy.
The screening questionnaire showed that there were no
cases with rheumatic disease or hypothyroidism. Body
mass index (BMI) and smoking habits were not assessed.
Seven patients had other risk factors for CTS, but none
had more than one risk factor (Table 4). Two patients
had type 2 diabetes mellitus (one in the unlikely group
and the other in the classic/probable group who previous-
ly had surgery bilaterally). Two patients reported previ-
ous wrist surgeries: one for a wrist fracture and the other
for a scaphoid fracture (both in classic/probable group).
Three patients reported working with vibrating tools (one
Table 4 Clinical, electrophysiological and ultrasonography results of heterozygotes (Cases 1–23)




1 M 74 P Neg/neg Neg/neg Pos 3 3 þþ 8 8
2 F 31 U Neg/neg Neg/30s Neg 0 0  9 9
3 F 52 C/P Neg/neg 60s/20s Neg 0 0 þ/ 12 14
4 M 75 C/P Pos/pos 10s/10s Pos 4 4 þþþ 16 17
5 M 75 DM Bilateral C/P Pos/neg 60s/30s Pos 4 3 þþþ 8 10
6 F 75 P Neg/neg Neg/40s Neg 3?a 0  9 8
7 F 57 Left C/P Neg/neg Neg/40s Pos 4 3 þþþ 13 11
8 M 25 VT U Neg/neg Neg/neg Neg 0 0  7 8
9 M 58 C/P Neg/neg 40s/40s Neg 0 0 þ/ 9 9
10 M 59 VT U Neg/neg Neg/neg Pos 4 4  12 13
11 F 26 Wrist frx C/P Neg/neg 40s/40s Neg 0 0 þ/ 5 6
12 M 26 U Neg/neg Neg/neg Neg 0 0  8 9
13 F 55 C/P Neg/neg 30s/30s Neg 0 0 þ/ 8 8
14 M 86 U Neg/neg 40s/40s Pos 4 4  8 9
15 F 64 DM U Neg/neg Neg/neg Neg 0 0  6 7
16 M 36 Scaphoid frx C/P Neg/neg 20s/20s Pos 3 0 þþþR, þ/L 8 11
17 F 61 Bilateral C/P Neg/neg Neg/30s Pos 2 2 þþþ 8 7
18 M 64 U Neg/neg Neg/neg Neg 0 0  6 6
19 F 82 Bilateral C/P Pos/neg 30s/30s Pos 4 4 þþþ 7 8
20 M 59 VT C/P Neg/neg 45s/15s Pos 3 4 þþþ 9 11
21 M 28 U Neg/neg Neg/neg Neg 0 0  6 9
22 F 70 U Neg/neg Neg/neg Neg 0 0  10 10
23 F 28 U Neg/neg Neg/neg Neg 0 0  5 5
C/P, classic/probable; CTSC, the likelihood of CTS based on the consensus criteria (Table 2); DM, diabetes mellitus; frx, fracture; L, left; P, possible; Q, quantity of changes seen on
NCS (Table 3); R, right; U, unlikely; US, ultrasonography of median nerve CSA at carpal tunnel inlet (mm2); VT, work with vibrating tools.
aA marked decrease in motor amplitudes but close to a normal sensory response does not meet the sensory criteria. A median nerve dysfunction other than CTS was suspected.
Table 5 Likelihood of CTS in the HSANV group based on the consensus criteria
Likelihood Number of patients Female Male Mean age (range) Risk factors
þþþ 7 (30%) 3 (43%) 4 (57%) 64 (36–82) 3 (43%)
þþ 1 (4%) 0 1 (100%) 74 0
þ/ 4 (17%) 3 (75%) 1 (25%) 48 (26–58) 1 (25%)
 3 (13%) 1 (33%) 2 (67%) 73 (59–86) 1 (33%)
 8 (35%) 4 (50%) 4 (50%) 42 (25–70) 2 (25%)
Total 23 11 12 55 (25–86) 7
Table 6 Prevalence of CTS in the HSANV group
Likelihood Number of patients Female Male
þþþ or þþ 8 out of 23 (35%) 3 (38%) 5 (63%)
þþþ, þþ or þ/ 12 out of 23 (52%) 6 (50%) 6 (50%)








s/article/2/2/fcaa085/5862628 by guest on 03 February 2021
in the classic/probable group and two in the unlikely
group).
Nerve conduction studies
Out of 23 patients, NCS identified 10 (44%) patients ful-
filling the electrophysiological criteria for CTS (9 bilateral
and 1 in the right hand only even though the participant
had bilateral symptoms). Out of these 19 wrists, the me-
dian nerve dysfunction was classified as severe in 11
(58%), moderate in 6 (32%) and mild in 2 (10%). Of
these 10 patients, 7 were in the classic/probable group, 1
in the possible group and 2 in the unlikely group. All
patients with a history of corrective surgery for CTS ful-
filled the NCS diagnostic criteria. For age-matched ana-
lysis of NCS controls, 2 patients who were above
79 years were excluded, leaving 8 out of 21 (38%)
patients with CTS. In the control group, 2 out of 30 sub-
jects (7%) were classified as having CTS of a very mild
degree. The Chi-square test showed a significant differ-
ence (Chi-square score 7.74; P¼ 0.005) between the
groups. NCS data are summarized in Supplementary
Table 2.
Prevalence of carpal tunnel
syndrome
The result of implementing the consensus criteria for CTS
(Rempel et al., 1998) is presented in Table 5. The preva-
lence of CTS in the HSANV group was 8 (35%) or 12
(52%) out of 23 depending on whether the 4 patients
with classic/probable history but negative NCS (Cases 3,
9, 11 and 13 in Table 4) were included or not (Table 6).
These four cases had, in common, symptoms that were
mild and intermittent, yet clinically definitely classic/prob-
able CTS and the physical examination with Phalen’s test
was positive.
There were two patients with an unlikely history for CTS
but with NCS showing severe median nerve dysfunction bi-
laterally (Cases 10 and 14 in Table 4). However, these did
not meet the consensus criteria for CTS diagnosis. There
was also one uncertain case (Case 6, Table 4) with possible
history and a right-sided marked decrease in motor ampli-
tudes of the median nerve on NCS but close to normal
sensory response, thus not fulfilling the sensory criteria. A
median nerve dysfunction other than CTS was suspected.
Ultrasonography
Individual patient data for nerve CSA are shown in
Table 4. When all patients were compared based on CTS
likelihood, no statistically significant difference in nerve
CSA was found (Kruskal–Wallis test: P¼ 0.1202).
Notably, all patients with surgically treated wrists had
normal or close to normal CSA (mean 8.4 mm2) despite
positive NCS and they were all in the þþþ group
(Table 4). Therefore, we sub-analysed the results with the
surgically treated wrists excluded (Table 7), and this
revealed a statistically significant difference in nerve CSA
between the groups (Kruskal–Wallis test: P¼ 0.0332).
Post hoc analysis revealed a significant difference in CSA
between the classic/probable (þþþ) and unlikely ()
groups [mean 6 standard deviation; (þþþ), 12.3 6 3.7
mm2; (), 7.5 6 1.7 mm2; Dunn’s multiple comparisons
test: P¼ 0.0296]. No difference was found for the other
patient groups (for nerve CSA of patients’ relatives with-
out the mutation see Supplementary Table 1).
Discussion
We found that individuals heterozygous for a point muta-
tion in the nerve growth factor-beta gene resulting in
HSANV have a very high prevalence of CTS. There was
good-to-excellent concordance between patient history,
Phalen’s test and NCS results. Tinel’s sign was not a reli-
able clinical test for the study group. The data analysis
was complicated by the fact that the criteria used
(Rempel et al., 1998) did not define a conclusive classifi-
cation for the þ/ group. Depending on whether these
were classified as CTS or not, the prevalence of CTS was
10–25 times higher (35–52%) for the study group than
the general Swedish population (2.1–3.6%) (Atroshi
et al., 1999). This finding is consistent with neurophysio-
logical, psychophysical and histological evidence from
clinical studies that the small-fibre function is affected in
entrapment neuropathies (Arendt-Nielsen et al., 1991;
Schmid et al., 2014).
Table 7 CSA at carpal tunnel inlet for the median nerve
Likelihood
of CTS
Nerve CSA Nerve CSA (operated wrists excluded)
þþþ 10.2 6 3.3 (7.0–17.0) N ¼ 13 12.3 6 3.7 (8.0–17.0) N ¼ 6
þþ 8.0 6 0.0 (8.0) N ¼ 2 None in the group had surgery
þ/ 9.1 6 2.8 (5.0–14.0) N ¼ 9 None in the group had surgery
 9.8 6 2.1 (8.0–13.0) N ¼ 6 None in the group had surgery
 7.5 6 1.7 (5.0–10.0) N ¼ 16 None in the group had surgery
All values are presented in mm2 as mean 6 standard deviation (range).
N, number of wrists.
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When the surgically treated wrists were included, we
found no statistically significant difference in the median
nerve CSA at the carpal tunnel inlet for those with CTS
in the HSANV group compared to those without CTS.
However, when the surgically treated wrists were
excluded, we found a significant difference in the median
nerve CSA at the carpal tunnel inlet between the patients
who had a high likelihood of CTS based on classic/prob-
able patient history with positive NCS compared to those
who had an unlikely patient history with negative NCS.
Previous reports on the use of ultrasound in other clinical
populations have also shown an increase in CSA of the
median nerve in CTS (Pinilla et al., 2008; Sarraf et al.,
2014). It remains to be tested whether the same applies
to homozygous carriers who have a more severe reduc-
tion in small fibres than in heterozygous carriers; how-
ever, none of the three known cases of the homozygous
phenotype have CTS (Einarsdottir et al., 2004). The
mechanisms underpinning nerve enlargement in response
to compression are not entirely clear but based on nerve
biopsies likely involve oedema, thickening of microvascu-
lar walls and fibrosis at the injury site (reviewed in
Rempel et al., 1999).
The current study population did not have abundant
risk factors for CTS, but a limitation of the current study
is that we did not assess the BMI and smoking habits.
However, none of the participants were visibly obese and
it seems unlikely that BMI, or smoking habits for that
matter, could explain the markedly high prevalence of
CTS. Indeed, the reason for a very high prevalence of
CTS in heterozygotes for the nerve growth factor-beta
mutation remains unknown. Diabetic polyneuropathy is
associated with an increased risk of CTS (Moon et al.,
2020) with several metabolic and vascular factors
involved that make the hyperglycaemic nerve more sus-
ceptible to compression at the carpal tunnel (e.g. Suzuki
et al., 1994). CTS is also commonly reported in chemo-
therapy-induced neuropathy (Miaskowski et al., 2017).
A recent mouse model of HSANV heterozygotes dis-
played reduced nociception and skin innervation but no
learning or memory deficits thus excluding haploinsuffi-
ciency as a mechanistic explanation (Testa et al., 2019).
A significant reduction in the nerve CSA was found in
the HSANV mouse model; the number of myelinated
axons was unaffected, but the unmyelinated axons were
significantly reduced (Testa et al., 2019). In our patient
population, a comparison between CTS positive (þþþ)
and CTS negative () patients revealed larger nerve CSA
in the CTS condition. The CSA of HSANV patients with-
out CTS was similar to relatives of these patients without
the mutation (data in Supplementary Table 1) and the
published normative data (e.g. Koyuncuoglu et al., 2005).
When comparing the sensory values of the ulnar nerve
of the fourth finger between the HSANV and the control
group in a post hoc analysis, there were significant differ-
ences in both amplitude and conduction velocity (data in
Supplementary Table 2). Since the ulnar nerve does not
pass through the carpal tunnel, CTS cannot explain this,
and it may reflect a more general nerve vulnerability in
the HSANV group. Here, the ulnar recordings were not
performed over the elbow, so cubital tunnel syndrome
cannot be ruled out—the second most common compres-
sion neuropathy after CTS in the upper extremity (Seror
and Nathan, 1993). Whether the high prevalence of CTS
in HSANV patients is due to focal or polyneuropathy
cannot be confirmed from current observations and
requires further investigations including conduction stud-
ies involving multiple nerves and body sites.
It was previously reported that tactile directional sens-
ibility, a sensitive measure of large (A-beta) fibre func-
tion, is normal in HSANV patients (Morrison et al.,
2011). In the current study, psychophysical testing
according to the protocol defined in the Michigan
Neuropathy Screening Instrument (Herman et al., 2012)
revealed that most patients were able to detect mechanic-
al stimuli on the great toe, albeit to a variable degree of
sensitivity, tested bilaterally using a 128-Hz tuning fork
or a 100-mN monofilament (data in Supplementary
Table 3). Several of these had foot deformities including
Charcot joints. In a recent study, we screened for thermal
function and found two patients in this cohort who had
no cold (<20C) or heat pain (>50C) perception and
yet their mechanical pain perception was intact, a feature
that from convergent evidence is likely signalled by the
large-diameter (A-beta) nociceptors (Nagi et al., 2019).
It might be speculated that due to relative pain insensi-
tivity, the HSANV patients use their wrists with excessive
repetitive motion, force, impulsiveness or in extreme posi-
tions leading to repeated microtrauma, the potential role
of which has been previously described in osteoarthritis
(Radin et al., 1991; Radin, 1995) and is consistent with
a high prevalence of osteoarthritis and Charcot arthropa-
thies in this group (Minde et al., 2009). However, further
studies on the pathophysiological mechanisms of CTS de-
velopment in HSANV are needed.
Supplementary material
Supplementary material is available at Brain
Communications online.
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